You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK):終止分拆廣州醫藥到境外上市及建議廣州醫藥於新三板掛牌

格隆匯12月19日丨白雲山(00874.HK)宣佈,其已於2023年12月19日舉行的會議上審議並批准(其中包括)有關終止廣州醫藥建議分拆及建議廣州醫藥於全國中小企業股份轉讓系統("新三板")掛牌,並將根據未來資本市場環境及戰略發展需要,擇機尋求在中國北京證券交易所上市。

考慮到中國證券監督管理委員會出具的《關於核准廣州醫藥股份有限公司發行境外上市外資股的批覆》之有效期已經在2022年6月23日屆滿,且目前資本市場的環境變化,結合公司及廣州醫藥的發展規劃,經審慎研究後,本公司及廣州醫藥決定終止推進建議分拆。

在符合相關法律法規政策和條件成熟的前提下,廣州醫藥擬聘任具有相應資質的主辦券商、會計師、律師等中介機構,申請廣州醫藥股票在新三板掛牌並公開轉讓。此次掛牌完成後,廣州醫藥將根據資本市場環境及戰略發展需要,未來擇機尋求在北京證券交易所上市。廣州醫藥此次掛牌不涉及發行股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account